CNTB

Healthcare Biotechnology

Connect Biopharma Holdings Limited

$0.95

+0.04 +4.77% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 7, 2026, live at 11:04 AM ET	0.95

Key Stats

Market Cap

60.04M

Avg Volume

3.77M

EPS

-$1.19

52W High

$3.82

52W Low

$0.85

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-1.37

P/B Ratio

2.23

P/S Ratio

20.33

EV/EBITDA

-0.38

EV/Revenue

8.85

Margins

Gross Margin 100.0%

Operating Margin (636.0%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

5666.7%

Return on Equity

(140.5%)

Return on Assets

(69.7%)

Liquidity & Leverage

Current Ratio

2.37

Quick Ratio

2.11

Debt / Equity

0.02

Total Cash

31.49M

Total Debt

596,000

About

Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.